BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 28278027)

  • 1. In silico investigation on the inhibition of Aβ
    Dutta M; Mattaparthi VSK
    J Biomol Struct Dyn; 2018 Feb; 36(3):741-752. PubMed ID: 28278027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Key Residue for Aggregation of Amyloid-β Peptides.
    Itoh SG; Yagi-Utsumi M; Kato K; Okumura H
    ACS Chem Neurosci; 2022 Nov; 13(22):3139-3151. PubMed ID: 36302506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissecting the Molecular Mechanisms of the Co-Aggregation of Aβ40 and Aβ42 Peptides: A REMD Simulation Study.
    Li X; Yang Z; Chen Y; Zhang S; Wei G; Zhang L
    J Phys Chem B; 2023 May; 127(18):4050-4060. PubMed ID: 37126408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new structural model of Alzheimer's Aβ42 fibrils based on electron paramagnetic resonance data and Rosetta modeling.
    Gu L; Tran J; Jiang L; Guo Z
    J Struct Biol; 2016 Apr; 194(1):61-7. PubMed ID: 26827680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyloid peptide Aβ40 inhibits aggregation of Aβ42: evidence from molecular dynamics simulations.
    Viet MH; Li MS
    J Chem Phys; 2012 Jun; 136(24):245105. PubMed ID: 22755606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The structures of the E22Δ mutant-type amyloid-β alloforms and the impact of E22Δ mutation on the structures of the wild-type amyloid-β alloforms.
    Coskuner O; Wise-Scira O; Perry G; Kitahara T
    ACS Chem Neurosci; 2013 Feb; 4(2):310-20. PubMed ID: 23421682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer's Aβ42 and Aβ40 form mixed oligomers with direct molecular interactions.
    Gu L; Guo Z
    Biochem Biophys Res Commun; 2021 Jan; 534():292-296. PubMed ID: 33272573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scrutiny of the mechanism of small molecule inhibitor preventing conformational transition of amyloid-β
    Shuaib S; Goyal B
    J Biomol Struct Dyn; 2018 Feb; 36(3):663-678. PubMed ID: 28162045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aβ42 and Aβ40: similarities and differences.
    Qiu T; Liu Q; Chen YX; Zhao YF; Li YM
    J Pept Sci; 2015 Jul; 21(7):522-9. PubMed ID: 26018760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alzheimer's Aβ42 and Aβ40 peptides form interlaced amyloid fibrils.
    Gu L; Guo Z
    J Neurochem; 2013 Aug; 126(3):305-11. PubMed ID: 23406382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-Terminus Binding Preference for Either Tanshinone or Analogue in Both Inhibition of Amyloid Aggregation and Disaggregation of Preformed Amyloid Fibrils-Toward Introducing a Kind of Novel Anti-Alzheimer Compounds.
    Dong M; Zhao W; Hu D; Ai H; Kang B
    ACS Chem Neurosci; 2017 Jul; 8(7):1577-1588. PubMed ID: 28406293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different Aggregation Pathways and Structures for Aβ40 and Aβ42 Peptides.
    Wang L; Eom K; Kwon T
    Biomolecules; 2021 Jan; 11(2):. PubMed ID: 33573350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aggregation of Aβ40/42 chains in the presence of cyclic neuropeptides investigated by molecular dynamics simulations.
    Wu M; Dorosh L; Schmitt-Ulms G; Wille H; Stepanova M
    PLoS Comput Biol; 2021 Mar; 17(3):e1008771. PubMed ID: 33711010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of the H6R and D7H Mutations on the Heparin-Dependent Modulation of Zinc-Induced Aggregation of Amyloid β].
    Radko SP; Khmeleva SA; Kiseleva YY; Kozin SA; Mitkevich VA; Makarov AA
    Mol Biol (Mosk); 2019; 53(6):1049-1056. PubMed ID: 31876283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the English familial disease mutation (H6R) on the monomers and dimers of Aβ40 and Aβ42.
    Viet MH; Nguyen PH; Derreumaux P; Li MS
    ACS Chem Neurosci; 2014 Aug; 5(8):646-57. PubMed ID: 24949887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. G37V mutation of Aβ42 induces a nontoxic ellipse-like aggregate: An in vitro and in silico study.
    Minh Thu TT; Huang SH; Tu LA; Fang ST; Li MS; Chen YC
    Neurochem Int; 2019 Oct; 129():104512. PubMed ID: 31374231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural Characterization of Amyloid β17-42 Dimer by Potential of Mean Force Analysis: Insights from Molecular Dynamics Simulations.
    Dutta M; Chutia R; Mattaparthi VSK
    Protein Pept Lett; 2017; 24(7):650-660. PubMed ID: 28641562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the Arctic (E22-->G) mutation on amyloid beta-protein folding: discrete molecular dynamics study.
    Lam AR; Teplow DB; Stanley HE; Urbanc B
    J Am Chem Soc; 2008 Dec; 130(51):17413-22. PubMed ID: 19053400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative analysis of co-oligomer formation by amyloid-beta peptide isoforms.
    Iljina M; Garcia GA; Dear AJ; Flint J; Narayan P; Michaels TC; Dobson CM; Frenkel D; Knowles TP; Klenerman D
    Sci Rep; 2016 Jun; 6():28658. PubMed ID: 27346247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solution NMR studies of Aβ monomer dynamics.
    Wang C
    Protein Pept Lett; 2011 Apr; 18(4):354-61. PubMed ID: 21222639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.